In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Savara (SVRA – Research Report), with a price ...

LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a ...

The Association of Performing Arts Professionals welcomed Tony-winner Kelli O’Hara to perform and speak at the APAP|NYC 2025 ...

This session aims to enhance awareness and understanding of aPAP among healthcare professionals, highlighting the disease’s impact and the journey toward accurate diagnosis. This focus on PAP at ...